Home/Pipeline/Bio-engineered Cornea

Bio-engineered Cornea

Corneal Disorders

Pre-clinicalActive

Key Facts

Indication
Corneal Disorders
Phase
Pre-clinical
Status
Active
Company

About Pandorum Technologies

Pandorum Technologies is a private, preclinical-stage biotech firm founded in 2011 and based in San Francisco, operating at the intersection of tissue engineering and regenerative medicine. Its core technology platform integrates bio-materials, cellular engineering, exosome/nanotherapy, and bio-fabrication techniques to build functional human tissues. The company's pipeline is led by a bio-engineered cornea product aimed at treating corneal disorders, supported by a mini-liver platform for drug discovery and an early-stage lung regeneration program. Pandorum is approaching clinical-stage development and has gained recognition in startup competitions and media lists.

View full company profile